Bone Growth Stimulators Market - Global Industry Analysis

Bone Growth Stimulators Market By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, and Platelet-Rich Plasma), By Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, and Others), By Distribution Channel (Hospitals & Clinics, Home Care, and Others) and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 30-Mar-2022 Category: Medical Device Report Format : PDF Pages: 154 Report Code: ZMR-6986 Status : Published

Request For Customization Request Free Brochure Request Free Sample Buy Now

Description

Industry Prospective:

The global bone growth stimulators market was worth around USD 1.21 billion in 2021 and is estimated to grow to about USD 1.85 billion by 2028, with a compound annual growth rate (CAGR) of approximately 5.2 percent over the forecast period. The report analyzes the bone growth stimulators market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the bone growth stimulators market.

Bone Growth Stimulators Market: Overview

Bone growth stimulation promotes bone healing in difficult-to-heal fractures or fusions by administering an ultrasonic or electrical current to the fracture site. This is done by an electrical osteogenesis stimulator, it’s a device that stimulates bone regeneration via electrical stimulation. Electrical stimulation can be administered from the outside (noninvasive) or the interior of the body (invasive). An external power supply is connected to electrodes or coil implanted on the skin or plaster or brace over a fusion or fracture site in a noninvasive electrical stimulator. A noninvasive device that generates low intensity, pulsed ultrasound is known as an ultrasonic osteogenesis stimulator. In order to encourage fracture healing, an ultrasonic signal is given to the skin surface at the fracture region through ultrasound conductive coupling gel.

COVID-19 Impact:

The COVID-19 pandemic is likely to have an interim negative impact on the global bone growth stimulators market. This is due to a sudden drop in elective surgeries, ban on organized sports, the momentary shutdown of O&P health centers, restricted access to non-essential care, and slowed in-patient flow & referrals. However, crucial European and Chinese markets are showing indications of revival. The market is expected to gradually rise in late in the second half of 2022, which could be attributed to handling pre-COVID elective surgeries, an increasing number of surgeries as a result of clearing backlogs & new cases, completely revived healthcare services, large-scale recreation & physical work, and the restarting of organized sports.

Bone Growth Stimulators Market: Growth Drivers

Increase patient preference towards minimally invasive and non-invasive surgical operations.

Because of the benefits offered by non-invasive and minimally invasive treatments over standard treatment techniques, there has been a huge growth in demand for them. Less operating problems, nominal hospitalization, smaller aesthetic incisions, less discomfort, minimal risk of infection, shortened postoperative care, and quicker recovery are all advantages of minimally invasive treatments. In minimally invasive treatments, advanced technology is used to detect and treat several disorders, including cancer. These treatments are intended to remove malignant tumors and lymph nodes from the body without leaving scars. These factors are contributing to the market growth.

Bone Growth Stimulators Market: Restraints

Limitations for medical reimbursement for bone stimulating procedures may hinder the market growth.

At a country level, medical reimbursement is one of the most important variables influencing the acceptance and demand of certain diagnostic or therapeutic goods among patients and healthcare professionals. In developed nations (such as the United States and Australia), the majority of healthcare insurance companies cover bone growth stimulation drugs provided certain requirements are met. In the United States, for example, insurance provided for bone growth stimulation devices providing the target bones are apart by less than one centimeter and are not diseased. According to the Part B schedule, Medicare also covers bone growth stimulating devices and provides device rental on a prescription basis but for various purposes. Moreover, many private insurance companies, on the other hand, do not cover or reimburse bone growth stimulating operations, thereby by hindering market growth to some extent.

Bone Growth Stimulators Market: Opportunities

Increasing demand for bone growth stimulators in emerging countries will provide better growth opportunities to the market.

Emerging economies like India, China, Mexico, and Brazil are likely to offer considerable growth potential for the bone growth stimulators market. Factors such as a large population of patients, soaring healthcare spending, increasing government support for the healthcare industry, bolstering export trade, and increasing awareness among surgeons, physicians, and patients regarding the latest treatment options for spinal fusion and bone therapies are estimated to bolster the requirement for bone growth stimulation devices. Furthermore, many patients from established countries are known to fly to these emerging nations for medical care because of the huge cost savings.

Bone Growth Stimulators Market: Challenges.

Side-effects of BMP-based orthopedic therapy pose a major challenge to expanding the market growth.

Even though BMPs are increasingly being employed in bone healing and spinal fusion, they are linked to several negative side effects. The most common adverse effects of BMPs following spinal fusion surgery include tissue edema, implant dislodgement, and male infertility. BMPs have been linked to antigenic responses and oncogene activation during bone repair. During the use of Medtronic's BMP product in spinal fusion procedures for bone repair, the company identified various clinical problems.

Bone Growth Stimulators Market: Segmentation

The global bone growth stimulators market is categorized into product, application, distribution channel, and region. Based on the product, the market is bifurcated into bone morphogenetic proteins, bone growth stimulation devices, and platelet-rich plasma. The application segment of the market is segregated as spinal fusion surgeries, oral & maxillofacial surgeries, delayed union & nonunion bone fractures, and others. The distribution channel segment is split into home care, hospitals & clinics, and others.

Report Scope:

Report Attribute	Details
Base Year	2020
Historic Years	2016 - 2020
Forecast Years	2021 - 2028
Segments Covered	By Product Type, By Application, and By End Use
Forecast Units	Value (USD Billion), and Volume (Units)
Quantitative Units	Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered	U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered	10 companies with scope for including additional 15 companies upon request
Report Coverage	Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope	Avail customized purchase options to meet your exact research needs.

Recent Developments

In April 2021, Orthofix has signed an exclusive licensing deal with IGEA to sell the company's breakthrough soft tissue, cartilage, and bone stimulation solutions in the United States and Canada.
In November 2020, Wright Medical was purchased by Stryker for USD 5.4 billion. Stryker's position in the orthopedics device industry was reinforced as a result of the purchase.
In June 2020, DePuy Synthes and the AO Foundation have extended their cooperation to promote patient care and outcomes via innovation and AO's independent worldwide education programs.

Bone Growth Stimulators Market: Regional Landscape

North America to remain the largest market for bone growth stimulators over the forecast period.

North America has the highest share of the global bone growth stimulators market. North America's significant market share is owing to a well-developed healthcare structure and medical reimbursement system in the United States and Canada. Along with that, increased physician and patient knowledge of novel treatment techniques and technologies in the United States and Canada is also supporting the regional market growth. Furthermore, the increasing incidences of spinal disorders, increasing geriatric population, higher population health risk due to smoking, obesity, & diabetes are also supporting the market growth. Additionally, increasing patient preference for non-invasive orthopedic treatments is fueling the market growth for bone growth stimulators in North America.

Bone Growth Stimulators Market: Competitive Landscape

Key players in the global bone growth stimulators market include Orthofix Medical, Inc., Zimmer Biomet, DJO Finance, LLC, Stryker, Bioventus LLC, Medtronic plc, Arthrex, Inc., DePuy Synthes, Isto Biologics, Ember Therapeutics, Inc., Terumo Corporation, Altis Biologics (Pty) Ltd., Ossatec Benelux Ltd., Regen Lab SA, Elizur Corporation, ITO Co., Ltd., and BTT Health GmbH.

Global bone growth stimulators market is segmented as follows:

By Product

Bone Growth Stimulation Devices
Bone Morphogenetic Proteins
Platelet-Rich Plasma

By Application

Spinal Fusion Surgeries
Delayed Union & Nonunion Bone Fractures
Oral & Maxillofacial Surgeries
Others

By Distribution Channel

Hospitals & Clinics
Home Care
Others

By Region

North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa

Table Of Content

Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
  - 1.3.1 Market Research Type
  - 1.3.2 Market research methodology
Chapter 2. Executive Summary
- 2.1 Global Bone Growth Stimulators Market, (2022 - 2028) (USD Billion)
- 2.2 Global Bone Growth Stimulators Market : snapshot
Chapter 3. Global Bone Growth Stimulators Market - Industry Analysis
- 3.1 Bone Growth Stimulators Market: Market Dynamics
- 3.2 Market Drivers
  - 3.2.1 Increase patient preference towards minimally invasive and non-invasive surgical operations will drive market growth
- 3.3 Market Restraints
  - 3.3.1. Limitations for medical reimbursement for bone stimulating procedures may hinder the market growth
- 3.4 Market Opportunities
  - 3.4.1. Increasing demand for bone growth stimulators in emerging countries will provide better growth opportunities to the market
- 3.5 Market Challenges
  - 3.5.1. Side-effects of BMP-based orthopedic therapy pose a major challenge to expanding market
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
  - 3.7.1 Market attractiveness analysis By Product
  - 3.7.2 Market attractiveness analysis By Application
  - 3.7.3 Market attractiveness analysis By Distribution Channel
Chapter 4. Global Bone Growth Stimulators Market- Competitive Landscape
- 4.1 Company market share analysis
  - 4.1.1 Global Bone Growth Stimulators Market: company market share, 2021
- 4.2 Strategic development
  - 4.2.1 Acquisitions & mergers
  - 4.2.2 New Product launches
  - 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
  - 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
Chapter 5. Global Bone Growth Stimulators Market - Product Analysis
- 5.1 Global Bone Growth Stimulators Market overview: By Product
  - 5.1.1 Global Bone Growth Stimulators Market share, By Product, 2021 and 2028
- 5.2 Bone Growth Stimulation Devices
  - 5.2.1 Global Bone Growth Stimulators Market by Bone Growth Stimulation Devices, 2022 - 2028 (USD Billion)
- 5.3 Bone Morphogenetic Proteins
  - 5.3.1 Global Bone Growth Stimulators Market by Bone Morphogenetic Proteins, 2022 - 2028 (USD Billion)
- 5.4 Platelet-Rich Plasma
  - 5.4.1 Global Bone Growth Stimulators Market by Platelet-Rich Plasma, 2022 - 2028 (USD Billion)
Chapter 6. Global Bone Growth Stimulators Market - Application Analysis
- 6.1 Global Bone Growth Stimulators Market overview: By Application
  - 6.1.1 Global Bone Growth Stimulators Market share, By Application, 2021 and 2028
- 6.2 Spinal Fusion Surgeries
  - 6.2.1 Global Bone Growth Stimulators Market by Spinal Fusion Surgeries, 2022 - 2028 (USD Billion)
- 6.3 Delayed Union & Nonunion Bone Fractures
  - 6.3.1 Global Bone Growth Stimulators Market by Delayed Union & Nonunion Bone Fractures, 2022 - 2028 (USD Billion)
- 6.4 Oral & Maxillofacial Surgeries
  - 6.4.1 Global Bone Growth Stimulators Market by Oral & Maxillofacial Surgeries, 2022 - 2028 (USD Billion)
- 6.5 Others
  - 6.5.1 Global Bone Growth Stimulators Market by Others, 2022 - 2028 (USD Billion)
Chapter 7. Global Bone Growth Stimulators Market - Distribution Channel Analysis
- 7.1 Global Bone Growth Stimulators Market overview: By Distribution Channel
  - 7.1.1 Global Bone Growth Stimulators Market share, By Distribution Channel, 2021 and 2028
- 7.2 Hospitals & Clinics
  - 7.2.1 Global Bone Growth Stimulators Market by Hospitals & Clinics, 2022 - 2028 (USD Billion)
- 7.3 Home Care
  - 7.3.1 Global Bone Growth Stimulators Market by Home Care, 2022 - 2028 (USD Billion)
- 7.4 Others
  - 7.4.1 Global Bone Growth Stimulators Market by Others, 2022 - 2028 (USD Billion)
Chapter 8. Bone Growth Stimulators Market - Regional Analysis
- 8.1 Global Bone Growth Stimulators Market Regional Overview
- 8.2 Global Bone Growth Stimulators Market Share, by Region, 2021 & 2028 (USD Billion)
- 8.3. North America
  - 8.3.1 North America Bone Growth Stimulators Market, 2022 - 2028 (USD Billion)
    - 8.3.1.1 North America Bone Growth Stimulators Market, by Country, 2022 - 2028 (USD Billion)
- 8.4 North America Bone Growth Stimulators Market, by Product, 2022 - 2028
  - 8.4.1 North America Bone Growth Stimulators Market, by Product, 2022 - 2028 (USD Billion)
- 8.5 North America Bone Growth Stimulators Market, by Application, 2022 - 2028
  - 8.5.1 North America Bone Growth Stimulators Market, by Application, 2022 - 2028 (USD Billion)
- 8.6 North America Bone Growth Stimulators Market, by Distribution Channel, 2022 - 2028
  - 8.6.1 North America Bone Growth Stimulators Market, by Distribution Channel, 2022 - 2028 (USD Billion)
- 8.4. Europe
  - 8.4.2 Europe Bone Growth Stimulators Market, 2022 - 2028 (USD Billion)
    - 8.4.2.1 Europe Bone Growth Stimulators Market, by Country, 2022 - 2028 (USD Billion)
- 8.4 Europe Bone Growth Stimulators Market, by Product, 2022 - 2028
  - 8.4.1 Europe Bone Growth Stimulators Market, by Product, 2022 - 2028 (USD Billion)
- 8.5 Europe Bone Growth Stimulators Market, by Application, 2022 - 2028
  - 8.5.1 Europe Bone Growth Stimulators Market, by Application, 2022 - 2028 (USD Billion)
- 8.6 Europe Bone Growth Stimulators Market, by Distribution Channel, 2022 - 2028
  - 8.6.1 Europe Bone Growth Stimulators Market, by Distribution Channel, 2022 - 2028 (USD Billion)
- 8.5. Asia Pacific
  - 8.5.3 Asia Pacific Bone Growth Stimulators Market, 2022 - 2028 (USD Billion)
    - 8.5.3.1 Asia Pacific Bone Growth Stimulators Market, by Country, 2022 - 2028 (USD Billion)
- 8.4 Asia Pacific Bone Growth Stimulators Market, by Product, 2022 - 2028
  - 8.4.1 Asia Pacific Bone Growth Stimulators Market, by Product, 2022 - 2028 (USD Billion)
- 8.5 Asia Pacific Bone Growth Stimulators Market, by Application, 2022 - 2028
  - 8.5.1 Asia Pacific Bone Growth Stimulators Market, by Application, 2022 - 2028 (USD Billion)
- 8.6 Asia Pacific Bone Growth Stimulators Market, by Distribution Channel, 2022 - 2028
  - 8.6.1 Asia Pacific Bone Growth Stimulators Market, by Distribution Channel, 2022 - 2028 (USD Billion)
- 8.6. Latin America
  - 8.6.4 Latin America Bone Growth Stimulators Market, 2022 - 2028 (USD Billion)
    - 8.6.4.1 Latin America Bone Growth Stimulators Market, by Country, 2022 - 2028 (USD Billion)
- 8.4 Latin America Bone Growth Stimulators Market, by Product, 2022 - 2028
  - 8.4.1 Latin America Bone Growth Stimulators Market, by Product, 2022 - 2028 (USD Billion)
- 8.5 Latin America Bone Growth Stimulators Market, by Application, 2022 - 2028
  - 8.5.1 Latin America Bone Growth Stimulators Market, by Application, 2022 - 2028 (USD Billion)
- 8.6 Latin America Bone Growth Stimulators Market, by Distribution Channel, 2022 - 2028
  - 8.6.1 Latin America Bone Growth Stimulators Market, by Distribution Channel, 2022 - 2028 (USD Billion)
- 8.7. The Middle-East and Africa
  - 8.7.5 The Middle-East and Africa Bone Growth Stimulators Market, 2022 - 2028 (USD Billion)
    - 8.7.5.1 The Middle-East and Africa Bone Growth Stimulators Market, by Country, 2022 - 2028 (USD Billion)
- 8.4 The Middle-East and Africa Bone Growth Stimulators Market, by Product, 2022 - 2028
  - 8.4.1 The Middle-East and Africa Bone Growth Stimulators Market, by Product, 2022 - 2028 (USD Billion)
- 8.5 The Middle-East and Africa Bone Growth Stimulators Market, by Application, 2022 - 2028
  - 8.5.1 The Middle-East and Africa Bone Growth Stimulators Market, by Application, 2022 - 2028 (USD Billion)
- 8.6 The Middle-East and Africa Bone Growth Stimulators Market, by Distribution Channel, 2022 - 2028
  - 8.6.1 The Middle-East and Africa Bone Growth Stimulators Market, by Distribution Channel, 2022 - 2028 (USD Billion)
Chapter 9. Company Profiles
- 9.1 Orthofix Medical Inc.
  - 9.1.1 Overview
  - 9.1.2 Financials
  - 9.1.3 Product Portfolio
  - 9.1.4 Business Strategy
  - 9.1.5 Recent Developments
- 9.2 Zimmer Biomet
  - 9.2.1 Overview
  - 9.2.2 Financials
  - 9.2.3 Product Portfolio
  - 9.2.4 Business Strategy
  - 9.2.5 Recent Developments
- 9.3 DJO Finance LLC
  - 9.3.1 Overview
  - 9.3.2 Financials
  - 9.3.3 Product Portfolio
  - 9.3.4 Business Strategy
  - 9.3.5 Recent Developments
- 9.4 Stryker
  - 9.4.1 Overview
  - 9.4.2 Financials
  - 9.4.3 Product Portfolio
  - 9.4.4 Business Strategy
  - 9.4.5 Recent Developments
- 9.5 Bioventus LLC
  - 9.5.1 Overview
  - 9.5.2 Financials
  - 9.5.3 Product Portfolio
  - 9.5.4 Business Strategy
  - 9.5.5 Recent Developments
- 9.6 Medtronic plc
  - 9.6.1 Overview
  - 9.6.2 Financials
  - 9.6.3 Product Portfolio
  - 9.6.4 Business Strategy
  - 9.6.5 Recent Developments
- 9.7 Arthrex Inc.
  - 9.7.1 Overview
  - 9.7.2 Financials
  - 9.7.3 Product Portfolio
  - 9.7.4 Business Strategy
  - 9.7.5 Recent Developments
- 9.8 DePuy Synthes
  - 9.8.1 Overview
  - 9.8.2 Financials
  - 9.8.3 Product Portfolio
  - 9.8.4 Business Strategy
  - 9.8.5 Recent Developments
- 9.9 Isto Biologics
  - 9.9.1 Overview
  - 9.9.2 Financials
  - 9.9.3 Product Portfolio
  - 9.9.4 Business Strategy
  - 9.9.5 Recent Developments
- 9.10 Ember Therapeutics Inc.
  - 9.10.1 Overview
  - 9.10.2 Financials
  - 9.10.3 Product Portfolio
  - 9.10.4 Business Strategy
  - 9.10.5 Recent Developments
- 9.11 Terumo Corporation
  - 9.11.1 Overview
  - 9.11.2 Financials
  - 9.11.3 Product Portfolio
  - 9.11.4 Business Strategy
  - 9.11.5 Recent Developments
- 9.12 Altis Biologics (Pty) Ltd.
  - 9.12.1 Overview
  - 9.12.2 Financials
  - 9.12.3 Product Portfolio
  - 9.12.4 Business Strategy
  - 9.12.5 Recent Developments
- 9.13 Ossatec Benelux Ltd.
  - 9.13.1 Overview
  - 9.13.2 Financials
  - 9.13.3 Product Portfolio
  - 9.13.4 Business Strategy
  - 9.13.5 Recent Developments
- 9.14 Regen Lab SA
  - 9.14.1 Overview
  - 9.14.2 Financials
  - 9.14.3 Product Portfolio
  - 9.14.4 Business Strategy
  - 9.14.5 Recent Developments
- 9.15 Elizur Corporation
  - 9.15.1 Overview
  - 9.15.2 Financials
  - 9.15.3 Product Portfolio
  - 9.15.4 Business Strategy
  - 9.15.5 Recent Developments
- 9.16 ITO Co. Ltd.
  - 9.16.1 Overview
  - 9.16.2 Financials
  - 9.16.3 Product Portfolio
  - 9.16.4 Business Strategy
  - 9.16.5 Recent Developments
- 9.17 BTT Health GmbH
  - 9.17.1 Overview
  - 9.17.2 Financials
  - 9.17.3 Product Portfolio
  - 9.17.4 Business Strategy
  - 9.17.5 Recent Developments

Table Of Figures

1. Market research Type
2. Market research methodology
3. Global Bone Growth Stimulators Market, 2022 - 2028 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Bone Growth Stimulators Market attractiveness, By Product
6. Global Bone Growth Stimulators Market attractiveness, By Application
7. Global Bone Growth Stimulators Market attractiveness, By Distribution Channel
8. Global Bone Growth Stimulators Market share by Product, 2022 and 2028 (USD Billion)
9. Global Bone Growth Stimulators Market by Bone Growth Stimulation Devices, 2022 - 2028 (USD Billion)
10. Global Bone Growth Stimulators Market by Bone Morphogenetic Proteins, 2022 - 2028 (USD Billion)
11. Global Bone Growth Stimulators Market by Platelet-Rich Plasma, 2022 - 2028 (USD Billion)
12. Global Bone Growth Stimulators Market share by Application, 2022 and 2028 (USD Billion)
13. Global Bone Growth Stimulators Market by Spinal Fusion Surgeries, 2022 - 2028 (USD Billion)
14. Global Bone Growth Stimulators Market by Delayed Union & Nonunion Bone Fractures, 2022 - 2028 (USD Billion)
15. Global Bone Growth Stimulators Market by Oral & Maxillofacial Surgeries, 2022 - 2028 (USD Billion)
16. Global Bone Growth Stimulators Market by Others, 2022 - 2028 (USD Billion)
17. Global Bone Growth Stimulators Market share by Distribution Channel, 2022 and 2028 (USD Billion)
18. Global Bone Growth Stimulators Market by Hospitals & Clinics, 2022 - 2028 (USD Billion)
19. Global Bone Growth Stimulators Market by Home Care, 2022 - 2028 (USD Billion)
20. Global Bone Growth Stimulators Market by Others, 2022 - 2028 (USD Billion)
21. Global Bone Growth Stimulators Market share, by Region, 2022 and 2028
22. North America Bone Growth Stimulators Market, 2022 - 2028 (USD Billion)
23. Europe Bone Growth Stimulators Market, 2022 - 2028 (USD Billion)
24. Asia Pacific Bone Growth Stimulators Market, 2022 - 2028 (USD Billion)
25. Latin America Bone Growth Stimulators Market, 2022 - 2028 (USD Billion)
26. The Middle-East and Africa Bone Growth Stimulators Market, 2022 - 2028 (USD Billion)

Table Of Tables

1. Global Bone Growth Stimulators Market: Snapshot
2. Drivers of the Bone Growth Stimulators Market: impact analysis
3. North America Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
4. North America Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
5. North America Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
6. U.S. Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
7. U.S. Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
8. U.S. Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
9. Canada Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
10. Canada Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
11. Canada Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
12. Europe Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
13. Europe Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
14. Europe Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
15. Germany Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
16. Germany Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
17. Germany Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
18. France Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
19. France Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
20. France Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
21. U.K. Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
22. U.K. Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
23. U.K. Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
24. Italy Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
25. Italy Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
26. Italy Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
27. Spain Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
28. Spain Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
29. Spain Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
30. Rest of Europe Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
31. Rest of Europe Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
32. Rest of Europe Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
33. Asia Pacific Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
34. Asia Pacific Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
35. Asia Pacific Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
36. China Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
37. China Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
38. China Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
39. Japan Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
40. Japan Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
41. Japan Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
42. India Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
43. India Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
44. India Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
45. South Korea Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
46. South Korea Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
47. South Korea Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
48. South-East Asia Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
49. South-East Asia Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
50. South-East Asia Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
51. Rest of Asia Pacific Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
52. Rest of Asia Pacific Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
53. Rest of Asia Pacific Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
54. Latin America Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
55. Latin America Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
56. Latin America Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
57. Brazil Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
58. Brazil Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
59. Brazil Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
60. Mexico Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
61. Mexico Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
62. Mexico Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
63. Rest of Latin America Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
64. Rest of Latin America Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
65. Rest of Latin America Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
66. The Middle-East and Africa Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
67. The Middle-East and Africa Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
68. The Middle-East and Africa Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
69. GCC Countries Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
70. GCC Countries Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
71. GCC Countries Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
72. South Africa Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
73. South Africa Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
74. South Africa Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)
75. Rest of Middle-East Africa Bone Growth Stimulators Market revenue, By Product, 2022 - 2028 (USD Billion)
76. Rest of Middle-East Africa Bone Growth Stimulators Market revenue, By Application, 2022 - 2028 (USD Billion)
77. Rest of Middle-East Africa Bone Growth Stimulators Market revenue, By Distribution Channel, 2022 - 2028 (USD Billion)

Methodology

Choose License Type

Single User License

$4199.00 Multi User License

$5199.00 Enterprise Access License

$7199.00

Request the coronavirus impact analysis across industries and markets

Request impact analysis
on this market

FrequentlyAsked Questions

Which key factors will influence bone growth stimulators market growth over 2022-2028?

High demand for minimally invasive treatments booting the market growth. Because of the benefits offered by non-invasive and minimally invasive treatments over standard treatment techniques, there has been a huge growth in demand for them. Less operating problems, nominal hospitalization, smaller aesthetic incisions, less discomfort, minimal risk of infection, shortened postoperative care, and quicker recovery are all advantages of minimally invasive treatments. In minimally invasive treatments advanced technology is used to detect and treat a several disorders, including cancer. These treatments are intended to remove malignant tumors and lymph nodes from the body without leaving scars. These factors are contributing to the market growth.

What will be the value of the bone growth stimulators market during 2022-2028?

According to the Zion Market Research report, the global bone growth stimulators market was worth about 1.21 (USD billion) in 2021 and is predicted to grow to around 1.85 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 5.2 percent.

Which region will contribute notably towards the bone growth stimulators market value?

North America has the highest share of the bone growth stimulators market. North America's significant market share is owing to well-developed healthcare structure and medical reimbursement system in the United States and Canada. Along with that, increased physician and patient knowledge of novel treatment techniques and technologies in the United States and Canada is also supporting the regional market growth. Furthermore, the increasing incidences of spinal disorders, increasing geriatric population, higher population health risk due to smoking, obesity, and diabetes are also supporting the market growth.

Which are the major players leveraging the bone growth stimulators market growth?

Key players in the global bone growth stimulator market include Orthofix Medical, Inc., Zimmer Biomet, DJO Finance, LLC, Stryker, Bioventus LLC, Medtronic plc, Arthrex, Inc., DePuy Synthes, Isto Biologics, Ember Therapeutics, Inc., Terumo Corporation, Altis Biologics (Pty) Ltd., Ossatec Benelux Ltd., Regen Lab SA, Elizur Corporation, ITO Co., Ltd., and BTT Health GmbH.